Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Lily Allen loves her two daughters, but her admission that she also loves getting away from them for some child-free time ...

Hims & Hers is the latest US corporation to donate $1 million to President-elect Donald Trump's ever-growing inauguration ...

Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight loss was its unintended side-effect. However, their real purpose has been ...

These are the images that show how a Bulgarian coke mule, who tried to smuggle €21 million of pure cocaine on a ship ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...